Ignite Creation Date:
2025-12-25 @ 2:51 AM
Ignite Modification Date:
2026-03-03 @ 2:42 PM
Study NCT ID:
NCT03939533
Status:
COMPLETED
Last Update Posted:
2023-11-07
First Post:
2019-05-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases
Sponsor:
Octapharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-17
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-03
Completion Date Type:
ACTUAL
First Submit Date:
2019-05-03
First Submit QC Date:
None
Study First Post Date:
2019-05-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-03-14
Results First Submit QC Date:
None
Results First Post Date:
2023-11-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-01
Last Update Post Date:
2023-11-07
Last Update Post Date Type:
ACTUAL